Telemedicine Dominates Healthcare
Share
Andrew Dudum shares his perspective on the massive digital transformation happening in healthcare, particularly accelerated by COVID-19, and his company's approach to building a sustainable telemedicine business.
-
Healthcare Digital Transformation:
- Projects approximately 80% of healthcare moving to digital telemedicine in next 5 years
- Believes healthcare is one of the last major sectors untouched by digital transformation
- Sees this as one of the biggest remaining business opportunities alongside retail, commerce, real estate, and transportation
-
COVID-19 Impact on Telemedicine:
- Significant acceleration in telemedicine adoption
- People staying home created natural shift to digital healthcare solutions
- Perfect solution when unable to visit physician's office in person
-
Business Approach and Vision:
- Building for long-term success:
- No desire for quick acquisition exit
- Aims to build multi-generational public company
- Current Business Status:
- Over $100 million in sales last year
- Conducted over 1 million telemedicine visits
- Currently not profitable but close to profitability
- Reinvesting profits into growth and new conditions
- Building for long-term success:
-
Marketing Strategy:
- Balanced approach:
- Majority of spending on efficient, accountable channels
- Portion allocated to brand building and relationship development
- Beyond Traditional Digital:
- Not solely dependent on Facebook/Instagram
- Explores diverse channels including dating apps, affiliate networks, education sites
- Focus on meeting customers where they are
- Balanced approach:
-
Current Market Environment:
- Survival is key focus:
- Companies need to find profitable cohorts and channels
- Efficient operations crucial in current market
- Survival equals growth in current climate
- Capital raising will be challenging:
- Flat rounds likely to be the new normal
- Less willingness to finance R&D and experimentation
- Survival is key focus:
Andrew Dudum
Founded Hims & Hers Health, a digital platform revolutionizing healthcare accessibility. Led the company to significant growth, reaching 1.86 million subscribers and $316 million in Q2 revenues.
Focuses on transforming healthcare through personalized solutions, including innovative treatments and compounded medications. Continues to expand the company's capabilities through strategic acquisitions and platform enhancements.